featured
Association of Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Autopsy Findings and VTE in Patients With COVID-19
- Call to Action to Prevent VTE in Hospitalized Patients
- High-Dose Heparin for Thromboprophylaxis in COVID-19 Patients May Not Be Justified
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients With COVID-19
- COVID-19 and Its Implications for Thrombosis and Anticoagulation
- DVT in Hospitalized Patients With COVID-19
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
J Am Coll Cardiol 2020 May 06;[EPub Ahead of Print], I Paranjpe, V Fuster, A Lala, A Russak, BS Glicksberg, MA Levin, AW Charney, J Narula, ZA Fayad, E Bagiella, S Zhao, GN NadkarniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.